These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 31124683)

  • 1. Enantioselective hydrogenation of olefins with phosphinooxazoline-iridium catalysts.
    Blackmond DG; Lightfoot A; Pfaltz A; Rosner T; Schnider P; Zimmermann N
    Chirality; 2000 Jun; 12(5-6):442-9. PubMed ID: 10824167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of lactones from diols mediated by an artificial flavin.
    Zhang X; Tan Z; Li C; Qi S; Xu M; Li M; Xiong W; Zhuang W; Liu D; Zhu C; Ying H
    Bioresour Bioprocess; 2021 Oct; 8(1):94. PubMed ID: 38650200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic enantioselective intramolecular Tishchenko reaction of
    Ismiyarto ; Kishi N; Adachi Y; Jiang R; Doi T; Zhou DY; Asano K; Obora Y; Suzuki T; Sasai H; Suzuki T
    RSC Adv; 2021 Mar; 11(19):11606-11609. PubMed ID: 35423664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generality-oriented optimization of enantioselective aminoxyl radical catalysis.
    Rein J; Rozema SD; Langner OC; Zacate SB; Hardy MA; Siu JC; Mercado BQ; Sigman MS; Miller SJ; Lin S
    Science; 2023 May; 380(6646):706-712. PubMed ID: 37200427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-phase bromination process using tetraalkylammonium hydroxide for the practical synthesis of α-bromolactones from lactones.
    Yamamoto Y; Tabuchi A; Hosono K; Ochi T; Yamazaki K; Kodama S; Nomoto A; Ogawa A
    Beilstein J Org Chem; 2021; 17():2906-2914. PubMed ID: 34956409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastereo- and enantioselective anti-selective hydrogenation of α-amino-β-keto ester hydrochlorides and related compounds using transition-metal-chiral-bisphosphine catalysts.
    Hamada Y
    Chem Rec; 2014 Apr; 14(2):235-50. PubMed ID: 24550034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iridium-catalyzed asymmetric hydrogenation of olefins.
    Roseblade SJ; Pfaltz A
    Acc Chem Res; 2007 Dec; 40(12):1402-11. PubMed ID: 17672517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Efficient Asymmetric Hydrogenation Catalyzed by Iridium Complexes with Tridentate Chiral Spiro Aminophosphine Ligands.
    Yang F; Xie JH; Zhou QL
    Acc Chem Res; 2023 Feb; 56(3):332-349. PubMed ID: 36689780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iridium-Catalyzed Asymmetric Hydrogenation of Unsaturated Carboxylic Acids.
    Zhu SF; Zhou QL
    Acc Chem Res; 2017 Apr; 50(4):988-1001. PubMed ID: 28374998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridium-catalyzed asymmetric hydrogenation of racemic α-substituted lactones to chiral diols.
    Yang XH; Yue HT; Yu N; Li YP; Xie JH; Zhou QL
    Chem Sci; 2017 Mar; 8(3):1811-1814. PubMed ID: 28451302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric hydrogenation of exocyclic γ,δ-unsaturated β-ketoesters to functionalized chiral allylic alcohols
    Bin HY; Cheng L; Wu X; Zhu CL; Yang XH; Xie JH; Zhou QL
    Chem Sci; 2021 Apr; 12(22):7793-7799. PubMed ID: 34168833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iridium-Catalyzed Asymmetric Hydrogenation of γ- and δ-Ketoacids for Enantioselective Synthesis of γ- and δ-Lactones.
    Hua YY; Bin HY; Wei T; Cheng HA; Lin ZP; Fu XF; Li YQ; Xie JH; Yan PC; Zhou QL
    Org Lett; 2020 Feb; 22(3):818-822. PubMed ID: 31961159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective Hydrogenation of Racemic α-Arylamino Lactones to Chiral Amino Diols with Site-Specifically Modified Chiral Spiro Iridium Catalysts.
    Gu XS; Yu N; Yang XH; Zhu AT; Xie JH; Zhou QL
    Org Lett; 2019 Jun; 21(11):4111-4115. PubMed ID: 31124683
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.